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ABSTRACT
Objective: Dexamethasone-induced Ras-related protein 1 (Dexras1) and Ras homolog enriched in striatum (RHES) are the two monomeric small G 
proteins that belong to Ras superfamily. These two proteins show 62% similarity. Both of these proteins are involved in signaling and modulation of 
several pathophysiological processes. They have unique GTP binding domain and a unique C and N terminus. C terminus is known to interact with 
several proteins; however, the role of its unique N terminus is still not known. The three-dimensional (3D) structure of these proteins is also not 
available in any of the databases yet. This present study approaches bioinformatics tools and servers to predict the 3D structure of these two proteins 
in silico.
Methods: In this study, two bioinformatics servers were used, namely Swiss modeling server and Iterative Threading ASSEmbly Refinement 
(I-TASSER) server.
Results: Both servers developed many alignment templates of Dexras1 and RHES. These alignments were used to develop 3D structure using Pymol. 
These models have different regions of proteins such as N terminus, GTP-binding domains, effector loop, C terminus, and the unique CAAX site. The 
models deduce that the N-terminals of both Dexras1 and RHES are unique regions that might possible be dangling out of the protein while it gets 
inserted into the membrane. We hypothesize that this unique N-terminal might have a distinct role in the modulation of N-type calcium channels.
Conclusion: All the models generated show predicted 3D structure of Dexras1 and RHES protein. This study of structural prediction will be helpful in 
knowing the interaction of Dexras1 and RHES and a step forward to target these two proteins as a novel therapeutic drug.
Keywords: G proteins, Homology modeling, Dexamethasone-induced Ras-related protein 1, Ras homolog enriched in striatum, Pathophysiological 
processes, Structure-function relationship, Iterative Threading ASSEmbly Refinement, Swiss server.
INTRODUCTION
Dexamethasone-induced Ras-related protein 1 (Dexras1) (also known 
as AGS1 or Rasd1) and Ras homolog enriched in striatum (RHES) (also 
known as Rasd2) are the monomeric G proteins, which are involved 
in many pathophysiological processes [1]. Expression of Dexras1 
(Rasd1 and formerly called as Activators of G-protein Signaling 1) is 
upregulated by dexamethasone and estriadiol and is expressed in many 
tissues [2-5]. Another monomeric closely resembling Dexras1 is (RHES, 
Rasd2) and it bears about 62% similarity to Dexras1 [6]. Both these 
monomeric Ras proteins show about 35% similarities to other members 
of Ras proteins [7,8]. They have similar GTP binding sites like all Ras 
proteins, but the C and N terminus are unique. Human Dexras1 is a 
30 kDa protein, 281 amino acids expressed in almost all tissue, whereas 
RHES is a protein with 266 amino acids and is primarily expressed 
in the brain and its expression is regulated by thyroid hormones. 
Both Dexras1 and RHES have been implicated in many signaling 
pathways [1] and have three prominent structural domains/conserved 
regions: (i) Four highly conserved GTP binding domains, (ii) Effector 
loop - might possibly participate in protein-protein interactions with 
other signaling molecules and is necessary for full biological activity, 
and (iii) A CAAX sequence at the end of C-terminal - a consensus site 
for isoprenylation CVIS [9]. All these conserved regions are thought to 
be important for the activity of Dexras1. Dexras1 has similar signaling 
properties as RHES in terms of modulation of N-type calcium channel 
Cav2.2 [10]. Their role in cardiovascular diseases, Huntington disease, 
regulation of rhythms, neurotransmitter-mediated behavior, and cancer 
has also been investigated [11-14].
The enormous range of activity that showed by the two monomeric 
proteins, Dexras1 and RHES, may involve some of their structural 
determinants/ domains, that might assist them in performing a wide 
range of functions. These monomeric Ras proteins have a unique C and 
N-terminal. The C-terminal has been shown to interact with proteins 
such as neuronal nitric oxide synthase (nNOS - stimulated by NMDA 
receptors) and PTB domain toward N-terminal of CAPON [15]. They 
suggested that the formation of trimeric complex between Dexras1, 
nNOS, and CAPON leads to S-nitrosylation of cysteine at 11th position 
(cys 11), resulting in an increased guanine-nucleotide exchange. Many 
other studies so far have implicated that C-terminal interactions and 
s-nitrosylation of cystein 11 are prominent strategies for the modulation 
of different signalling pathways. However, questions such as what is the 
role of unique N-terminal region of Dexras1 in the modulation of N-type 
calcium ion channels (Cav2.2) still remain. Most of the studies carried 
out until date focus on investigating modulation of signaling pathways 
by Dexras1 and RHES. Although the general framework of different 
domains has been illustrated by Graham et al. 2002, to date, the role 
of N-terminal of Dexras1 and RHES in the modulation of voltage-gated 
Cav2.2 or any other interacting protein has not been investigated.
As the function(s) of its N-terminal of Dexras1 and RHES are still unknown, 
so to predict the interaction of N-terminal, we applied an in‑silico 
approach. Although the sequences of both proteins are known and the 
GTP-binding domains present in the core of protein well marked, we still 
do not understand the molecular mechanism of these two monomeric 
proteins by which they modulate different physiological mechanisms.
Research Article
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The in silico approach for the modeling of different chemicals and their 
structural analysis has been reported by many researchers. Sahare and 
Moon [16] used in silico strategies to find ligand binding efficiencies 
of the active site of PBP4 toward selected β-lactam antibiotics as well 
as phytochemicals. They reported the highest binding affinity to the 
active site pocket of PBP4 of β-lactam resistant Enterococcus faecalis 
isolated from uropathological samples of urinary tract-infected patients. 
This study could be useful in designing more effective phytoligand-
based therapeutic antibacterial compounds against PBP4 of E. faecalis. 
Another researcher, Gupta et al. [17] also used bioinformatics tools 
to reveal the secondary structure features and characterization of an 
enzyme SOD and its different isoforms which might be beneficial for 
oxidative stress management in plants during germination phases. 
In our study, we also have used different in silico approaches. As 
the experimentally determined crystal structure of the two above-
mentioned proteins (Dexras1 and RHES) is not available, so with the 
help of bioinformatics tools, we have tried to develop a hypothesis about 
the unique three-dimensional (3D) structure of these proteins and also 
Dexras1 RHES
MODEL1 of Dexras1, Template 4efm. 1.A, Seq Identity Coverage 38.04%, 
Description GTPase HRas, Oligostate: Monomer, Ligands None, GMQE 0.40, 
QMEAN4-4.82,
MODEL1 of RHES, Template 3kko. 1.A, Seq Identity 
Coverage 40.36% Description Ras-related protein M-Ras, 
Oligostate: Monomer, Ligands 1 x MG, GMQE 0.41, 
QMEAN4-4.22,
MODEL2 of Dexras1, Template 2ery. 1.A, Seq Identity Coverage 40.24%, 
Description Ras-related protein R-Ras2, Oligostate: Monomer, Ligands 
None, GMQE 0.40, QMEAN4-4.17,
MODEL2 of RHES, Template 2fn4.1.A, Seq Identity 
Coverage 42.01%Description Ras-related protein 
R-Ras, Oligostate: Monomer, Ligands None, GMQE 0.44, 
QMEAN4-4.03,
MODEL3 of Dexras1, Template 4dst. 1.A, Seq Identity Coverage 38.73%, 
Description GTPase KRas, isoform 2B, Oligostate: Monomer, Ligands None, 
GMQE 0.40, QMEAN4-7.19,
MODEL3 of RHES, Template 2erx. 1.A, Seq Identity 
Coverage 45.45%Description GTP-binding protein 
Di-Ras2, Oligostate: Monomer, Ligands None, GMQE 0.47, 
QMEAN4-2.35
MODEL4 of Dexras1, Template 3rap. 1.B, Seq Identity Coverage 39.88%, 
Description PROTEIN (G protein RAP2A), Oligostate: Monomer (matching 
prediction), Ligands None, GMQE 0.42, QMEAN4-3.94, 
MODEL4 of RHES, Template 2gf0.1.A, Seq Identity 
Coverage 46.91%Description GTP-binding protein 
Di-Ras1, Oligostate: Monomer, Ligands None, GMQE 0.46, 
QMEAN4-3.59
MODEL5 of Dexras1, Template 2gf0.1.A, Seq Identity Coverage 43.21%, 
Description GTP-binding protein Di-Ras1, Oligostate: Monomer, Ligands 
None, GMQE 0.43, QMEAN4-4.38, 
MODEL5 of RHES, Template 4tqa. 1.A, Seq Identity 
Coverage 39.02%Description GTPase KRas, Oligostate: 
Monomer, Ligands None, GMQE 0.47, QMEAN4-3.68
Fig. 1: Models of Dexamethasone-induced Ras-related protein 1 and Ras homolog enriched in striatum generated by Swiss homology 
modeling server
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In the present study, we have used two homology modeling servers, 
namely Swiss homology modeling and Iterative Threading ASSEmbly 
Refinement (I-TASSER) server, to predict the 3D structure of the proteins.
Method
Swiss model server [20] is a server for automated comparative 
modeling of 3D protein structures. All homology-modeling methods 
consist of the following four steps: (i) Template selection, (ii) target-
template alignment, (iii) model building, and (iv) evaluation. Energy 
minimization or molecular dynamic methods are in general not able to 
improve the accuracy of the models and are used in Swiss model only to 
regularize the structure.
Our query for Dexras1 protein homology modeling by Swiss server 
generated several templates and we developed five models based on five 
templates, namely, (a) GTPase HRas (pdb ID 4efm.1.A, identity 38.04%), 
(b) Ras-related protein R-Ras2 (pdb ID - 2ery.1.A, identity 40.24%), 
(c) GTPase KRas, isoform 2B (pdb ID - 4dst.1.A, identity 38.73%), (d) 
PROTEIN - G protein RAP2A (pdb ID 3rap.1.B, identity 39.88%), and 
(e) GTP-binding protein Di-Ras1 (pdb ID - 2gf0.1.A, identity 43.21%); 
Similar approach was also used for RHES and our query generated 
several templates and we developed five models based on five templates, 
namely, (a) Ras-related protein M-Ras (pdb ID - 3kko.1.A, identity 
40.36%), (b) Ras related protein R-Ras (pdb ID - 2fn4.1.A, identity 
42.01%), (c) GTP-binding protein Di-Ras2 (pdb ID - 2erx.1.A, identity 
45.45%), (d) GTP-binding protein Di-Ras1 (pdb ID 2gf0.1.A, identity 
46.91%), and (e) GTPase KRas (pdb ID 4tqa.1.A, identity 39.02%).
The second approach was based on the I-TASSER Server. It is an online 
server built in the Yang Zhang Lab at the University of Michigan, Ann 
Arbor, allowing users to submit sequences and obtain structure and 
function predictions. (Server link - http://zhanglab.ccmb.med.umich.
edu/I-TASSER/, Zhang-server, University of Michigan, USA). I-Tasser 
server uses slightly different approaches to build protein models. 
In general, Swiss server produces homology protein structures on 
the bases of template alignment, while in I-Tasser server, full-length 
structure models are constructed by reassembling structural fragments 
from threading templates.
I-TASSER server
I-TASSER is a bioinformatics method for predicting 3D structure 
model of protein molecules from amino acid sequences [21]. It detects 
structure templates from the Protein Data Bank by a technique called 
fold recognition (or threading). The full-length structure models are 
constructed by reassembling structural fragments from threading 
templates using replica exchange Monte Carlo simulations [21].
I-TASSER has been extended for structure-based protein function 
predictions, which provides annotations on ligand binding site, gene 
ontology, and enzyme commission by structurally matching structural 
models of the target protein to the known proteins in protein function 
databases [22].
This server uses multiple-threading alignments by local meta-
threading-server and iterative template fragment assembly simulations 
and the function insights are derived by matching the 3D models 
with BioLiP protein function database. The query for the structure 
of Dexras1 and RHES (same accessions numbers) was submitted to 
the server, and we received the detailed coordinates for five models 
each of Dexras1 and RHES. This coordinate file was converted into 
an pdb file, and details of the 3D conformations were generated and 
labeled using PYMOL (The PyMOL Molecular Graphics System, Version 
1.5.0.4 Schrödinger, LLC.), while the free energies for each structure 
were computed using SPDBV (http://www.expasy.org/spdbv/). The 
validation of the structures has been done using The Structure Analysis 
and Verification Server version 4. This meta server runs seven 
programs named as PROCHECK, WHAT_CHECK, ERRAT, VERIFY 3D, 
PROVE CRYST1 record matches, Ramachandran Plot, WedMol Viewer 
Rasd1 model1 Rasd2 model1
Rasd1 model2 Rasd2 model2
Rasd1 model3 Rasd2 model3
Rasd1 model4 Rasd2 model4
Rasd1 model5 Rasd2 model5
Fig. 2: Models of dexamethasone-induced Ras-related protein 1/
Rasd1 and Ras homolog enriched in striatum/Rasd2 generated 
by Iterative Threading ASSEmbly Refinement server using Pymol 
software
tried that the models obtained by bioinformatics tools might provide 
some information about the structure and interaction of these proteins.
MATERIALS AND METHODS
Experimental procedures
On the basis of the previous study [10], it has been reported that these two 
proteins are involved in modulation of N-type calcium channels. Protein 
sequences of human Dexras1 (Accession number: AF498923) and RHES 
(Accession number BC013419) were retrieved from the National Center 
for Biotechnology Information and queried in FASTA format.
Homology modeling is an approach to construct the atomic-resolution 
model of the “target” protein from its amino acid sequence. The method 
produces experimental 3D structure of a related homologous protein 
(the “template”) which relies on the identification of one or more 
known protein structures likely to resemble the structure of the query 
sequence. Moreover, this approach is also based on the production of 
an alignment that maps residues in the query sequence to residues 
in the template sequence to produce homologous 3D structure of the 
experimental protein [18]. The homology modeling procedure can be 
broken down into four sequential steps: Template selection, target-
template alignment, model construction, and model assessment [19].
There are a number of free servers that create homology models (also 
called comparative models) for a submitted amino acid sequence or that 
offer libraries of 3D models created in advance for protein sequences. 
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Fig. 3: Ramachandran plots of the five models (developed by Iterative Threading ASSEmbly Refinement) of dexamethasone-induced 
Ras-related protein 1/Rasd1 using “The Structure Analysis and Verification Server version 4”
Plot statistics 
Residues in most favoured regions [A, B, L]  181 73.3%
Residues in additional allowed regions [a, b, l, p]  46 18.6%
Residues in generously allowed regions [~a,~b,~l,~p] 11 4.5%
Residues in disallowed regions 9    3.6%
      ---- ----
Number of non-glycine and non-proline residues  247 100.0%
Number of end-residues (excl. Gly and Pro)  4
Number of glycine residues (shown as triangles)  18
Number of proline residues    2 ----
Total number of residues    281
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater 
than 20%, a good quality model would be expected to have over 90% in the most favoured regions.
Plot statistics
Residues in most favoured regions [A, B, L]  191 77.3%
Residues in additional allowed regions [a, b, l, p] 38 15.4%
Residues in generously allowed regions [~a,~b,~l,~p] 10 4.0%
Residues in disallowed regions 8   3.2%
----      ---- ------
Number of non-glycine and non-proline residues  247 100.0%
Number of end-residues (excl. Gly and Pro)  4
Number of glycine residues (shown as triangles)  18
Number of proline residues    12
      ----
Total number of residues    281
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater 
than 20%, a good quality model would be expected to have over 90% in the most favoured regions.
Plot statistics
Residues in most favoured regions [A, B, L]  183 73.5%
Residues in additional allowed regions [a, b, l, p]  42 16.9%
Residues in generously allowed regions [~a,~b,~l,~p] 13 5.2%
Residues in disallowed regions 11    4.4%
      ---- ------
Number of non-glycine and non-proline residues  249 100.0%
Number of end-residues (excl. Gly and Pro)  2
Number of glycine residues (shown as triangles)  18
Number of proline residues    12
Total number of residues    ----
      281
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater 
than 20%, a good quality model would be expected to have over 90% in the most favoured regions
Plot statistics
Residues in most favoured regions [A, B, L]  190 76.9%
Residues in additional allowed regions [a, b, l, p]  44 17.8%
Residues in generously allowed regions [~a,~b,~l,~p] 8 3.2%
Residues in disallowed regions 5    2.0%
      ---- ------
Number of non-glycine and non-proline residues  247 100.0%
Number of end-residues (excl. Gly and Pro)  4
Number of glycine residues (shown as triangles)  18
Number of proline residues    12
      ----
Total number of residues    281
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater 
than 20%, a good quality model would be expected \to have over 90% in the most favoured regions.
Plot statistics
Residues in most favoured regions [A, B, L]  149  60.3%
Residues in additional allowed regions [a, b, l, p]  62 25.1%
Residues in generously allowed regions [~a,~b,~l,~p] 24 9.7%
Residues in disallowed regions  12    4.9%
      ---- ------
Number of non-glycine and non-proline residues  247 100.0%
Number of end-residues (excl. Gly and Pro)  4
Number of glycine residues (shown as triangles)  18
Number of proline residues    12
      ----
Total number of residues    281
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater 
than 20%, a good quality model would be expected to have over 90% in the most favoured regions.
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Fig. 4: Ramachandran plots of the five models (developed by Iterative Threading ASSEmbly Refinement) of Ras homolog enriched in 
striatum/Rasd2 using “The Structure Analysis and Verification Server version 4”
Plot statistics
Residues in most favoured regions [A, B, L]  175 73.8%
Residues in additional allowed regions [a, b, l, p]  46 19.4%
Residues in generously allowed regions [~a,~b,~l,~p] 8 3.4%
Residues in disallowed regions    8 3.4%
       ---- ------
Number of non-glycine and non-proline residues  237 100.0%
Number of end-residues (excl. Gly and Pro)  4
Number of glycine residues (shown as triangles)  13
Number of proline residues    12
      ----
Total number of residues 266
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater than 20%, 
a good quality model would be expected to have over 90% in the most favoured regions.
 Plot statistics
Residues in most favoured regions [A, B, L]  194 81.9%
Residues in additional allowed regions [a, b, l, p]  29 12.2%
Residues in generously allowed regions [~a,~b,~l,~p] 8 3.4%
Residues in disallowed regions    6 2.5%
 ---- ------
Number of non-glycine and non-proline residues  237 100.0%
Number of end-residues (excl. Gly and Pro)  4
Number of glycine residues (shown as triangles)  13
Number of proline residues    12
      ----
Total number of residues    266
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater than 20%, 
a good quality model would be expected to have over 90% in the most favoured regions
Plot statistics
Residues in most favoured regions [A, B, L 187  78.2%
Residues in additional allowed regions [a, b, l, p] 38 15.9%
Residues in generously allowed regions [~a,~b,~l,~p] 7 2.9%
Residues in disallowed regions    7 2.9%
      ---- ------
Number of non-glycine and non-proline residues  239 100.0%
Number of end-residues (excl. Gly and Pro)  2
Number of glycine residues (shown as triangles)  13
Number of proline residues    12
      ----
Total number of residues    266
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater than 20%, 
a good quality model would be expected to have over 90% in the most favoured regions.
Plot statistics
Residues in most favoured regions [A, B, L]  187 78.2%
Residues in additional allowed regions [a, b, l, p]  29 12.1%
Residues in generously allowed regions [~a,~b,~l,~p] 14 5.9%
Residues in disallowed regions 9    3.8%
      ---- ------
Number of non-glycine and non-proline residues  239 100.0%
Number of end-residues (excl. Gly and Pro)  2
Number of glycine residues (shown as triangles)  13
Number of proline residues    12
      ----
Total number of residues    266
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater than 20%, 
a good quality model would be expected to have over 90% in the most favoured regions.
Plot statistics
Residues in most favoured regions [A, B, L]  150 62.8%
Residues in additional allowed regions [a, b, l, p]  57 23.8%
Residues in generously allowed regions [~a,~b,~l,~p] 19 7.9%
Residues in disallowed regions 13    5.4%
      ---- ------
Number of non-glycine and non-proline residues  239 100.0%
Number of end-residues (excl. Gly and Pro)  2
Number of glycine residues (shown as triangles)  13
Number of proline residues    12 
      ----
Total number of residues    266
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater than 20%, 
a good quality model would be expected to have over 90% in the most favoured regions.
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(link http://nihserver.mbi.ucla.edu/SAVES) for checking and validating 
protein structures during and after model refinement.
RESULTS
Homology models for the structural prediction of Dexras1 and RHES 
have been done using two different homology modeling servers:
First, structural model of Dexras1 and RHES was done using homology 
modeling by Swiss server. In this approach, the sequences of dexras1 
and RHES were run on Swiss server. This server developed different 
models based on the template structures available in the server. The 
models generated using this approach are represented in a panel 
of figures in Fig. 1 for Dexras1and RHES. All these models generated 
showing 38–46 % identity with the existing protein models.
The sequences were also submitted to I-TASSER SERVER. This server 
computed relative positions of amino acid and developed a model, and 
it also integrated the known templates and their probable structures. 
This server also computed five different hypothetical models and 
calculates their lowest free energy states also. The models developed 
using this server are represented in Fig. 2 which include rasd1 m1, 
rasd2m2, rasd3m3, rasd4m4, and rasd5m5 for Dexras1/Rasd1 and 
rasd2m1, rasd2m2, rasd2m3, rasd2m4, and rasd2m5 for RHES/Rasd2.
These models deduce that the N-terminals of both Dexras1 and RHES 
are unique regions that might possible be dangling out of the protein 
(non-random domains), while it gets inserted into the membrane. We 
hypothesize that this unique N-terminal might have a distinct role in 
the modulation of N-type calcium channels.
Validation of the structures
The structures generated after using I-Tasser server were validated using 
“The Structure Analysis and Verification Server version 4.” This meta 
server runs different programs named as PROCHECK, WHAT_CHECK, 
ERRAT, VERIFY 3D, PROVE, CRYST1 record matches, Ramachandran 
Plot, and WedMol Viewer (link http://nihserver.mbi. Ucla.edu/SAVES), 
for checking and validating protein structures during and after model 
refinement. The results generated for all the programs have been 
saved in Pdf files, which includes prove plots, Ramachandran plot of all 
residues, ProCheck PDF files, and a verification plot, for all the models 
of the two proteins. The Ramachandran plots generated for all the 
models are represented in Fig. 3 for Dexras1/Rasd1 and Fig. 4 for RHES/
Rasd2, showing some of the residues falls under disallowed region in the 
analysis of Ramachandran Plot, whereas most of the residues falls under 
most favored regions together with allowed regions.
Simultaneously, new validated pdb version has been obtained using 
the Structure Validation and Quality server MolProbity (link: http://
molprobity.biochem.duke.edu/) for structure validation on client-
uploaded or PDB ID-specified files, using all-atom contact analysis tools 





Dexras1 and RHES, both proteins are involved in modulation of many 
physiological processes, but the 3D structure and the exact mechanism 
of modulation involved are not known yet. In the present study, in‑silico 
approach has been used to predict the 3D structure of these proteins 
which might be helpful in prediction of probable mechanisms of signaling 
involved in different physiological processes. Our present study is a step 
forward in understanding the structure-function relationship of Dexras1 
with special reference to modulation of N-type calcium channels.
Our 3D predicted model indicates that the N-terminal domain between 
1 and 21–24 amino acids might form a random dispersive domain. 
This domain can attain various configurations but still be functional, 
and this domain might contribute toward receptor-mediated inhibition 
of Cav2.2 either by direct interaction or through an adaptor protein. 
The “random dispersive N-Terminal domain” still needs to be proven 
experimentally.
CONCLUSION
Dexras1 and RHES, both the GTP binding monomeric proteins have 
reported to influence many physiological processes and signaling 
mechanisms of many diseases. They both could be targeted as a potential 
pharmaceutical and therapeutic drug in future. The 3D structure of these 
two proteins will be helpful to know the interaction of these proteins. 
The 3D structure yet not described in any of the database. Our study 
for the prediction of 3D structure of these proteins by in silico method 
will be a step forward in knowing the interaction of these proteins 
with the other interactive proteins. This structural prediction might 
become the bases to know the exact molecular mechanisms involved 
in interactions and signaling of these two proteins, and it will also be 
helpful in further experimentation and hypothesizing the mechanism 
involved in signaling and modulation of physiological processes.
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